Filing Flows › Actinium Pharmaceuticals (ATNM) › Who owns the stock
Who owns Actinium Pharmaceuticals (ATNM) stock
43 funds reported Actinium Pharmaceuticals (ATNM) shares in their latest 13F filings, worth $7.0M in all. The largest holder is Vanguard Group ($1.9M). Last quarter 9 funds added to their stakes and 30 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Vanguard Group | 1,421,038 | $1.9M | increase | 2025-12-31 |
| Vanguard Capital Management LLC | 1,238,302 | $1.2M | decrease | 2026-06-30 |
| Compass Financial Management LLC | 600,230 | $588K | base | 2026-06-30 |
| Millennium Management LLC | 514,580 | $504K | decrease | 2026-06-30 |
| Acadian Asset Management LLC | 496,288 | $485K | decrease | 2026-06-30 |
| BlackRock | 395,896 | $388K | increase | 2026-06-30 |
| Renaissance Technologies LLC | 380,491 | $373K | decrease | 2026-06-30 |
| Geode Capital Management, LLC | 324,945 | $319K | decrease | 2026-06-30 |
| Two Sigma Investments, LP | 259,179 | $254K | decrease | 2026-06-30 |
| Gagnon Securities LLC | 182,142 | $178K | decrease | 2026-06-30 |
| Vanguard Fiduciary Trust | 161,526 | $158K | increase | 2026-06-30 |
| State Street | 122,215 | $120K | decrease | 2026-06-30 |
| Northern Trust | 69,743 | $68K | decrease | 2026-06-30 |
| Qube Research & Technologies | 57,812 | $57K | increase | 2026-06-30 |
| Vontobel Holding | 50,000 | $56K | unchanged | 2026-09-30 |
Actinium Pharmaceuticals' latest quarter
Actinium Pharmaceuticals, Q2 2026: revenue $35.0M, operating margin 78.8%, net earnings $27.9M, operating cash flow −$5.2M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most ATNM stock?
By the latest 13F filings: Vanguard Group ($1.9M); Vanguard Capital Management LLC ($1.2M); Compass Financial Management LLC ($588K); Millennium Management LLC ($504K); Acadian Asset Management LLC ($485K).
What is the short interest in ATNM?
631,234 shares were sold short at the 2026-10-15 settlement, -10.57% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.